(Q53371627)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Si Young Song

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Hye Won Chung

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Sunphil Jang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Kyong Joo Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Kyung Hwa Park

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

30 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

1714-1721

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

The value of carcinoembryonic antigen measurement in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

HMG-1 as a late mediator of endotoxin lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

HMGB1 and RAGE in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

High-mobility group box 1 and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Masquerader: high mobility group box-1 and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02358.X

Role of tumour markers, cytogenetics

21 January 2018

1 reference

12 December 2020

Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen

1 reference

12 December 2020

[Early cancer of the exocrine pancreas: diagnosis and prognosis]

1 reference

12 December 2020

Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Extraordinarily elevated CA19-9 in benign conditions: a case report and review of the literature.

1 reference

12 December 2020

[Inhibitory effects of high mobility group box 1 antisense nucleotide on invasion of human pancreatic cancer cell line PCNA-1]

1 reference

12 December 2020

Reporting recommendations for tumor marker prognostic studies

1 reference

12 December 2020

Pelvic reduction during pyeloplasty for antenatal hydronephrosis: does it affect outcome in ultrasound and nuclear scan postoperatively?

1 reference

12 December 2020

Differential expression of RAGE in human pancreatic carcinoma cells

1 reference

12 December 2020

10.1111/J.1349-7006.2012.02358.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PMC publication ID

7659219

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22703527%20AND%20SRC:MED&resulttype=core&format=json